Clinical Trials
3 trialsNCT01678313 2014-07-15
Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels
Buddhist Tzu Chi General Hospital
Phase 2 Completed
NCT00410514 2014-04-04
A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
Astellas Pharma Inc
Phase 2 Completed
NCT01078545 2012-01-16
LEMON
Abbott
Completed